Vioxx


Also found in: Thesaurus, Medical, Wikipedia.
Related to Vioxx: Celebrex
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Vioxx - a Cox-2 inhibitor (trade name Vioxx) that relieves pain and inflammation without harming the digestive tract; voluntarily withdrawn from the market in 2004
Cox-2 inhibitor - an anti-inflammatory drug that fights pain and blocks Cox-2 activity without impeding the activity of Cox-1; increases the risk of heart attacks; "Cox-2 inhibitors reduce the symptoms of arthritis without endangering the stomach and kidneys"
brand, brand name, marque, trade name - a name given to a product or service
References in periodicals archive ?
The new Celebrex commercial, which urges consumers to "understand the risks, see the benefits," of the drug, is meant to dispel confusion in the minds of consumers between Celebrex and Vioxx. Sales of Celebrex dropped nearly 50% after the market withdrawal of Vioxx, although it has recovered somewhat since then, according to USA Today.
recalled its arthritis drug Vioxx because a study showed that it doubled the risk of heart attacks and strokes in patients taking the drug for 18 months or more.
When arthritis sufferer Maureen Chapman was prescribed so-called wonder drug Vioxx, she had high hopes it would soothe her pain.
They reported on two drugs--Merck & Co.'s Vioxx and Pfizer Inc.'s Celebrex--in a study that sought to determine whether pharmaceutical companies can influence physician and patient decisions about adopting pharmaceutical therapy.
in Louisiana federal court, claiming that the painkiller Vioxx had caused heart attacks and strokes and that Merck had omitted to warn them of these risks.
Merck & Co., Inc., admitted last month that a key position it has taken regarding the safety of its arthritis drug Vioxx was based on faulty data.
There are two main Cox-2 inhibitors, Vioxx and Celebrex, both of which were heavily advertised in recent years.
The findings come as some Welsh families are trying to sue the makers of the drug Vioxx, which was withdrawn in September 2004 because it was linked to an increased risk of heart attacks and stroke.
A product liability trial against its Cox-2 inhibitor drug Vioxx in Angleton, Texas, resulted in the quarter-billion dollar award, $229 million of which was for punitive damages.
The firm is looking for more people who may have suffered a heart attack or stroke while taking Vioxx. The arthritis treatment was prescribed to 400,000 patients in the UK before it was withdrawn in September last year when a study showed it doubled the risk of heart attack or stroke when taken for at least 18 months.
But as the recent Angleton, Texas, jury's verdict against Vioxx shows, you'd be wrong.